News & Investors

Annual General Meeting

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

General Shareholders‘ Meeting

Dear Shareholders,

The Extraordinary General Shareholders’ Meeting of Epigenomics AG has taken place on November 27, 2020 at 13:00 p.m. (CET) as a virtual event without the physical presence of the shareholders in Munich. The presence amounted to around 41% of the share capital. Shareholders approved all agenda items according to the Board’s proposal.

 

Voting results of the Extraordinary General Shareholders’ Meeting 2020 (German only) PDF
Invitation to the Extraordinary General Shareholders’ Meeting 2020 of Epigenomics AG PDF
Letter to the Shareholders PDF
Report of the Executive Board on agenda item 2 PDF
Subscription and Backstop Agreement PDF
Annual Report 2019
(incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report)
PDF
Balance Sheet of Epigenomics AG (German HGB) as of September 30, 2020 (German only) PDF
Information on data protection PDF

 

Corporate Governance/Declaration of Governance

2019
Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) – October 2020 PDF
Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) PDF

 

Further information

Explanation of Shareholders’ rights PDF
Articles of Association PDF

 

 



Archive